Cara Therapeutics, Inc. (CARA) Prioritizes Late-Stage Notalgia Paresthetica Program

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into…

Canopy Growth Corporation (CGC) Announces Upsized US$35 Million Private Placement

Canopy Growth Announces Upsized US$35 Million Private Placement Canopy Growth Corporation (“Canopy…